EMD Serono Inc., Merck KGaA’s North American drug development business, plans to move its U.S. headquarters to Boston’s Seaport District from its longtime home in Rockland next summer.
The drugmaker is taking two floors of office space, or just over 60,000 square feet, at 200 Pier 4 Blvd. It has about 400 employees assigned to its Rockland office right now, although some work remotely. The new space will have room for about 200 employees at a time, and the company has an option to expand to other floors in the building over time.
STAY IN THE KNOW
 |
Watch NBC10 Boston news for free, 24/7, wherever you are. |
 |
Get Boston local news, weather forecasts, lifestyle and entertainment stories to your inbox. Sign up for NBC Boston’s newsletters. |
More on this story from Boston Business Journal
Get top local stories in Boston delivered to you every morning. Sign up for NBC Boston's News Headlines newsletter.
